To interpret these differences in survival, the higher percentage of characteristics suggestive of better BC prognosis in women who participated in some of these studies, such as earlier stages and positive estrogen and progesterone receptors, must be taken into account (7, 11). The gene discussed is PGR; the disease is breast cancer.